Showing results (351-360 of 371) with videos related to
Sort By:
Pageof 38
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|August 30, 2021
Evaluation of spin in the abstracts of emergency medicine systematic reviews and meta-analysesMatthew C Ferrell, Jace Schell, Ryan Ottwell, et al.Osteoarthritis and Cartilage Open|December 7, 2022
Evaluation of spin in the abstracts of systematic reviews and meta-analyses covering surgical management, or quality of life after surgical management, of osteoarthritis of the kneeParker Siex, William Nowlin, Ryan Ottwell, et al.European Journal of Anaesthesiology|July 7, 2022
Evaluation of spin in the abstracts of systematic reviews and meta-analyses relating to postoperative nausea and vomitingMatthew Bruns, Arvind Manojkumar, Ryan Ottwell, et al.Melanoma Management|December 12, 2025
Assessing patient risk, benefit, and outcomes in drug development: a decade of vemurafenib clinical trialsTaylor Gardner, Jacob Duncan, Griffin K Hughes, et al.Journal of Osteopathic Medicine|July 2, 2021
Spin in the abstracts of systematic reviews and metaanalyses focused on percutaneous coronary interventionWesley Tanner Cole, Peter Wittl, Wade Arthur, et al.Targeted Oncology|March 11, 2024
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Lenvatinib Clinical Trials: A Systematic ReviewPatrick Crotty, Karim Kari, Griffin K Hughes, et al.Arthritis Care & Research|October 4, 2022
Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors' Self-Citation Rate in Japan and the United StatesHanano Mamada, Anju Murayama, Sae Kamamoto, et al.BMJ Oncology|January 31, 2025
Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trialsBrody Dennis, Chance Bratten, Griffin K Hughes, et al.Pain and Therapy|August 6, 2025
Adherence to CONSORT-PRO Extension Guidelines for Patient-Reported Outcomes in Randomized Controlled Trials Focused on Peripheral Nerve Blocks: A Meta-epidemiological StudyAdam Khan, Tiffany Nguyen, Bryan Dunford, et al.Cancer Medicine|May 3, 2024
Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trialsAdam Khan, Hassan Khan, Griffin K Hughes, et al.Pageof 38